bacterial infections
DiaSorin Nabs CE Marking for Legionella Immunoassay
The firm said it will sell its Liaison Legionella Urinary Antigen Immunodiagnostic Assay in all countries that accept the CE mark.
The firm recently received a European Innovation Council grant worth €5.7 million, and is planning further clinical validation of its platform while it eyes a US entry as soon as next year.
DiaSorin, MeMed Ink Italian Distribution Deal for Test to Differentiate Bacterial, Viral Infection
The partnership enables DiaSorin to distribute the MeMed BV test on the Liaison XL and XS as well as on the MeMed Key point-of-need system.
Meridian Bioscience Nabs FDA Clearance for Shiga Toxin Assay
The immunoassay expands Meridian's gastrointestinal product line with a test that can help identify infections with Shiga toxin-producing Escherichia coli.
Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium
Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.